Accord Logo

Intended for UK patients and members of the public

Co-codamol 8mg/500mg effervescent tablets

Co-codamol 8mg/500mg effervescent tablets

PL Number:
0142/1258
MA Holder:
Accord-UK Ltd
Product Classification:
P
Product Status:
Active

Product Documentation

  • Description of update: IB C.3.a: To update SmPC sections 4.2, 4.4, 4.8 and PIL in line with MHRA recommendation following review of PSUSA/00000851/202503 to amend directions in terms of opioid drug disorder (OUD).

    IB C.3.b: To update SmPC sections 4.2, 4.4, 4.5, 4.8 and PIL in line with PRAC recommendation (PSUSA/00000851/202503). Additionally, there are editorial and QRD updates to SmPC sections 4.4 (15 mg/500 mg & 30 mg/500 mg only) and the PIL. There are editorial updates to SmPC section 4.8 (15 mg/500 mg & 30 mg/500 mg only).

    Date of approval: 11/04/2026

    SmPC sections updated: 4.2, 4.4, 4.5, 4.8 and 10

  • Description of update: IB C.3.a: To update SmPC sections 4.2, 4.4, 4.8 and PIL in line with MHRA recommendation following review of PSUSA/00000851/202503 to amend directions in terms of opioid drug disorder (OUD).

    IB C.3.b: To update SmPC sections 4.2, 4.4, 4.5, 4.8 and PIL in line with PRAC recommendation (PSUSA/00000851/202503). Additionally, there are editorial and QRD updates to SmPC sections 4.4 (15 mg/500 mg & 30 mg/500 mg only) and the PIL. There are editorial updates to SmPC section 4.8 (15 mg/500 mg & 30 mg/500 mg only).

    Date of approval: 11/04/2026

    PIL sections updated: Introduction, 2, 3, 4, 5 and 6

If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the Yellow Card Scheme at yellowcard.mhra.gov.uk. By reporting side effects, you can help provide more information on the safety of this medicine.

Report a side effect or a product complaint

For any further assistance, please get in touch.

View product information as a: